Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | LAP3 | P28838 | 2/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.35 |
| ▸ | PGK1 | P00558 | 3/20 | 0.33 |
| ▸ | PGK2 | P07205 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxidronic Acid SCHEMBL29363818 | 0.96 | KDM4E (0.38) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Oxidronic Acid SCHEMBL8958458 | 0.96 | KDM4E (0.38) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Oxidronic Acid SCHEMBL28460122 | 0.96 | KDM4E (0.38) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Oxidronic Acid SCHEMBL1478075 | 0.96 | KDM4E (0.38) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Oxidronic Acid SCHEMBL4611796 | 0.89 | KDM4E (0.33) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| SCHEMBL17954018 | 0.78 | CA2 (0.44) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| SCHEMBL919194 | 0.76 | — | — | |
| Oxidronic Acid SCHEMBL28460123 | 0.75 | SLC34A1 (0.47) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| Oxidronic Acid SCHEMBL1649745 | 0.75 | SLC34A1 (0.39) | KDM4EMMP2THRBMAPK1HSD17B10 | |
| SCHEMBL10831667 | 0.73 | KDM4E (0.40) | KDM4EMMP2THRBMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4619431-A1 | METHODS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS | Neurimmune AG (CH) | 2025-09-24 | — | — | EP | claimed |
| CN-119089235-B | Customer service risk assessment and early warning method and system based on historical data | 北京华档致远科技有限公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025054524-A1 | METHOD FOR DIAGNOSING AMYLOID DISEASES | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-03-13 | — | — | WO | claimed |
| CN-119528315-A | Stable reducing iron-sulfur-based slurry and preparation method and application thereof | 南京师范大学 | 2025-02-28 | — | — | CN | claimed |
| CN-119439655-A | Corrosion-resistant developing solution and preparation method and application thereof | 上海戎洲芯科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119418559-A | Hierarchical conflict detection and resolution method based on ADS-B data validity | 培风智行(天津)科技有限责任公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119220617-A | Method for synthesizing pyrrole-2-ethyl formate by lipase catalysis | 江南大学 | 2024-12-31 | — | — | CN | claimed |
| CN-119089235-A | Customer service risk assessment and early warning method and system based on historical data | 北京华档致远科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| US-20240299568-A1 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | WILLIAM MARSH RICE UNIVERSITY (US) | 2024-09-12 | — | — | US | claimed |
| WO-2024105062-A1 | METHODS FOR TREATING OR PREVENTING TRANSTHYRETIN-MEDIATED AMYLOIDOSIS | NEURIMMUNE AG (CH) | 2024-05-23 | — | — | WO | claimed |
| EP-0111415-A2 | Process for making lyophilized radiographic imaging kit | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1984-06-20 | — | — | EP | claimed |
| EP-0111414-A2 | Radiographic imaging agents | Mallinckrodt, Inc. (a Delaware corporation) (US) | 1984-06-20 | — | — | EP | claimed |
| US-4455291-A | IMAGES | NEW ENGLAND NUCLEAR CORPORATION (US) | 1984-06-19 | — | — | US | claimed |
| US-4451451-A | Radiopharmaceutical composition based on technetium-99m and reagent for making it | AMERSHAM INTERNATIONAL PLC (GB) | 1984-05-29 | — | — | US | claimed |
| US-4440646-A | HYDROXY OR HALOALKANEPHOSPHONATES | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1984-04-03 | — | — | US | claimed |
| US-4410442-A | FATTY ACID | THE PROCTER & GAMBLE COMPANY (US) | 1983-10-18 | — | — | US | claimed |
| EP-0078642-A2 | Radiopharmaceutical composition based on technetium-99m and reagent for making it | AMERSHAM INTERNATIONAL plc (GB) | 1983-05-11 | — | — | EP | claimed |
| US-4240920-A | A SURFACTANT, A PEROXY BLEACH AND A PORPHINE BLEACH | THE PROCTER & GAMBLE COMPANY (US) | 1980-12-23 | — | — | US | claimed |
| US-4188234-A | STABILIZATION OF VINYL POLYMERS, POLYPHOSPHONIC ACID CHELATING AGENT, PROTECTIVE COATINGS | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1980-02-12 | — | — | US | claimed |
| US-4116990-A | OF NON-ALKALI METAL IONS WITH PHOSPHORUS CHELATING COMPOUND | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1978-09-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299568-A1 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | SOST, BST2, ACP3 | KDM4E 4204/4885MMP2 485/4885THRB 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.